Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.

[1]  T. Barth,et al.  H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant , 2017, Histopathology.

[2]  S. Aubert,et al.  H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach , 2017, Modern Pathology.

[3]  A. Flanagan,et al.  Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone , 2017 .

[4]  A. Flanagan,et al.  The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma , 2016, Histopathology.

[5]  R. Mohankumar,et al.  Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. , 2016, European journal of cancer.

[6]  John B Wojcik,et al.  Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone , 2016, The American journal of surgical pathology.

[7]  A. Cleton-Jansen,et al.  Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma , 2015, The American journal of surgical pathology.

[8]  D. Campanacci,et al.  Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series , 2015, Journal of Clinical Pathology.

[9]  T. Ueda,et al.  Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  A. B. Hassan,et al.  Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics , 2015, The journal of pathology. Clinical research.

[11]  J. Partridge,et al.  Histone H3 mutations—a special role for H3.3 in tumorigenesis? , 2015, Chromosoma.

[12]  L. Sullivan,et al.  A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas , 2014, Acta Neuropathologica.

[13]  M. Chou,et al.  USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. , 2014, Human pathology.

[14]  M. Stratton,et al.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone , 2013, Nature Genetics.

[15]  David M. Thomas,et al.  Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. , 2013, The Lancet. Oncology.

[16]  Gurmit Singh,et al.  Giant cell tumor of bone: a basic science perspective. , 2013, Bone.

[17]  David M. Thomas,et al.  Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone , 2012, Clinical Cancer Research.

[18]  L. Gong,et al.  Histological and clinical characteristics of malignant giant cell tumor of bone , 2012, Virchows Archiv.

[19]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[20]  A. Puri,et al.  Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India. , 2008, Annals of diagnostic pathology.

[21]  F. Mertens,et al.  Molecular identification of COL6A3‐CSF1 fusion transcripts in tenosynovial giant cell tumors , 2008, Genes, chromosomes & cancer.

[22]  村田 淳.  Osteoblast lineage properties in giant cell tumors of bone , 2005 .

[23]  S. Kumta,et al.  Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. , 2004, Bone.

[24]  M. Szendrői.  Giant-cell tumour of bone. , 2004 .

[25]  F. Bertoni,et al.  Malignancy in giant cell tumor of bone , 2003, Cancer.

[26]  K. Wakabayashi,et al.  Platelet‐Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  I. James,et al.  Human osteoclastoma‐derived stromal cells: Correlation of the ability to form mineralized nodules in vitro with formation of bone in vivo , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  J. Struthers,et al.  Giant-Cell Tumour of Bone , 1939, Edinburgh medical journal.